hotspot -WSS

hotspot

author：hotspot 2025-09-27 22:49:59 - browse：51

Transparent plastic divider on the reception desk in the hospital admission department with red lettering emergency. — Adobe

QuidelOrtho has recalled nearly 8,000 potentially faulty blood tests meant to help doctors quickly determine whether a patient is having a heart attack.

The tests inaccurately showed low levels of troponin, a protein that indicates damage to the heart. A false negative could lead doctors to mistakenly conclude their patient is not having a heart attack, delaying diagnosis or treatment when time is of the essence.

The device maker, which also sells products like the QuickVue Covid-19 antigen test, sent letters to health systems in May telling them to immediately stop using the test. The Food and Drug Administration classified the recall as serious, because problems with the product could result in serious injury or death. QuidelOrtho has reported 41 complaints, but no injuries or deaths so far.

The tests, which use either a blood or plasma sample, promise to return results in under half an hour. They are used in emergency rooms to triage patients suspected of having a heart attack.

Related: With Wegovy and Ozempic’s success, can device makers keep up in the race to treat obesity?

The FDA said the patients most at risk are those with zero or abnormal heart attack symptoms, for whom a diagnosis would be easy to miss without an accurate lab test.

The company advised using a different testing method to detect heart attacks. If none are available, doctors should be extra wary of the blood panel’s readings, perform multiple tests to confirm low troponin levels, and also reference data from EKGs and other imaging.

San Diego-based QuidelOrtho said the error is due to a “raw material issue” in its recall record. The issue caused the test to falsely pick up 30% less troponin than is present. The company did not respond to STAT’s request for more information on the error.

The test maker’s last serious recall was in 2021 for reports of false negatives from its Lyra PCR Covid-19 test when used with certain lab equipment. The notice impacted more than 18,000 test kits.

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Gilgo Beach: Police identify another victim in serial killing investigation

WSS

Election results set back Medicaid expansion plans

Judge in Trump's classified documents case questions use of out

Doctors are clamoring for more clarity on Paxlovid prescribing

White House drug shortage group privately met with industry

Influencer to be charged after chaos erupts in New York City's Union Square

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

entertainment

hotspot

Related: With Wegovy and Ozempic’s success, can device makers keep up in the race to treat obesity?

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

Tori Bowie and the unacceptable rates of Black maternal death

Judge in Trump's classified documents case questions use of out

Alkermes shareholders re

White House drug shortage group privately met with industry

How one medical school became remarkably diverse

OTC birth control: A brief history of over the counter pill design

Medicare proposal to cover medical devices draws a mixed reaction

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

leisure time

The drug industry sees a key ally in the Senate prevail

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

Stem cell clinics for heart failure: buyer be wary

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

With heat waves through August, officials warn of health risks

Verily hires former Apple Health leader as chief scientific officer

entertainment

hotspot

hotspot

explore